| Rite Aid Pharmacy 05274 | |
| 15801 Pacific Ave S, Tacoma, Washington 98444 | |
| (253) 531-7427 |
| Name | Rite Aid Pharmacy 05274 |
|---|---|
| Organization Name | Thrifty Payless Inc |
| Location | 15801 Pacific Ave S, Tacoma, Washington 98444 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (253) 531-7427 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Children suffering from a cancer of the nervous system could benefit from a potential new treatment, thanks to an international team led by researchers at the University of Kent and at the Institute of Medical Virology at the Goethe-University, Frankfurt am Main, Germany.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
A NEW funding scheme launched by Cancer Research UK today (Thursday) looks to bring new insight to some of cancer's biggest challenges.
Pfizer Inc. has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate.
› Verified 1 days ago
| NPI Number | 1639288947 |
| Organization Name | THRIFTY PAYLESS INC |
| Doing Business As | RITE AID PHARMACY 05274 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 15801 Pacific Avenue South, Spanaway Village Shopping Center, Tacoma, WA 98444 |
| Phone Number | 253-531-7427 |
News Archive
Children suffering from a cancer of the nervous system could benefit from a potential new treatment, thanks to an international team led by researchers at the University of Kent and at the Institute of Medical Virology at the Goethe-University, Frankfurt am Main, Germany.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
A NEW funding scheme launched by Cancer Research UK today (Thursday) looks to bring new insight to some of cancer's biggest challenges.
Pfizer Inc. has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate.
› Verified 1 days ago
News Archive
Children suffering from a cancer of the nervous system could benefit from a potential new treatment, thanks to an international team led by researchers at the University of Kent and at the Institute of Medical Virology at the Goethe-University, Frankfurt am Main, Germany.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
A NEW funding scheme launched by Cancer Research UK today (Thursday) looks to bring new insight to some of cancer's biggest challenges.
Pfizer Inc. has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate.
› Verified 1 days ago
Sav-on Pharmacy #0493 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 104 Military Rd S, Tacoma, Washington 98444 Phone: (253) 538-2611 | |
Arris Health Services Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 4002 Tacoma Mall Blvd, Tacoma, Washington 98409 Phone: (858) 997-5367 | |
Bellevue Healthcare Ii Inc Pierce Type: DME Supplier - Oxygen Equipment & Supplies Location: 1007 South J St, Tacoma, Washington 98405 Phone: (253) 274-8500 | |
American Medical Rental & Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4358 S Washington St, Tacoma, Washington 98409 Phone: (253) 473-3055 | |
Elite Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6002 Westgate Blvd, Tacoma, Washington 98406 Phone: (206) 234-6182 |